track name="MYNN (@ All cell types) 50" url="http://chip-atlas.org/view?id=$$" gffTags="on"
chr1 10025 10459 ID=SRX360015;Name=MYNN%20(@%20LoVo);Title=GSM1239583:%20batch5%20chrom1%20LoVo%20MYNN%20Rabbit%20FailedQC%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Digestive%20tract;
source_name=LoVo;cell%20line=LoVo;cell%20type=colon%20adenocarcinoma;hgn=MYNN;antibody=Abcam%20:%20ab66273;control%20sample=batch5_chrom1_LoVo_IgG_Rabbit;qc%20successful=FailedQC;fraction%20of%20peaks%20close%20to%20tss=0.060241;lowest%20e-value%20for%20a%20high%20complexity%20de%20novo%20motif=1; 162 . 10025 10459 0,165,255
chr1 4362958 4363497 ID=SRX360015;Name=MYNN%20(@%20LoVo);Title=GSM1239583:%20batch5%20chrom1%20LoVo%20MYNN%20Rabbit%20FailedQC%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Digestive%20tract;
source_name=LoVo;cell%20line=LoVo;cell%20type=colon%20adenocarcinoma;hgn=MYNN;antibody=Abcam%20:%20ab66273;control%20sample=batch5_chrom1_LoVo_IgG_Rabbit;qc%20successful=FailedQC;fraction%20of%20peaks%20close%20to%20tss=0.060241;lowest%20e-value%20for%20a%20high%20complexity%20de%20novo%20motif=1; 326 . 4362958 4363497 0,255,177
chr1 91852656 91853070 ID=SRX360015;Name=MYNN%20(@%20LoVo);Title=GSM1239583:%20batch5%20chrom1%20LoVo%20MYNN%20Rabbit%20FailedQC%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Digestive%20tract;
source_name=LoVo;cell%20line=LoVo;cell%20type=colon%20adenocarcinoma;hgn=MYNN;antibody=Abcam%20:%20ab66273;control%20sample=batch5_chrom1_LoVo_IgG_Rabbit;qc%20successful=FailedQC;fraction%20of%20peaks%20close%20to%20tss=0.060241;lowest%20e-value%20for%20a%20high%20complexity%20de%20novo%20motif=1; 201 . 91852656 91853070 0,205,255
chr1 121478656 121478936 ID=SRX360015;Name=MYNN%20(@%20LoVo);Title=GSM1239583:%20batch5%20chrom1%20LoVo%20MYNN%20Rabbit%20FailedQC%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Digestive%20tract;
source_name=LoVo;cell%20line=LoVo;cell%20type=colon%20adenocarcinoma;hgn=MYNN;antibody=Abcam%20:%20ab66273;control%20sample=batch5_chrom1_LoVo_IgG_Rabbit;qc%20successful=FailedQC;fraction%20of%20peaks%20close%20to%20tss=0.060241;lowest%20e-value%20for%20a%20high%20complexity%20de%20novo%20motif=1; 153 . 121478656 121478936 0,156,255
chr1 121483988 121485571 ID=SRX360015;Name=MYNN%20(@%20LoVo);Title=GSM1239583:%20batch5%20chrom1%20LoVo%20MYNN%20Rabbit%20FailedQC%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Digestive%20tract;
source_name=LoVo;cell%20line=LoVo;cell%20type=colon%20adenocarcinoma;hgn=MYNN;antibody=Abcam%20:%20ab66273;control%20sample=batch5_chrom1_LoVo_IgG_Rabbit;qc%20successful=FailedQC;fraction%20of%20peaks%20close%20to%20tss=0.060241;lowest%20e-value%20for%20a%20high%20complexity%20de%20novo%20motif=1; 1000 . 121483988 121485571 255,0,0
chr1 142967411 142967863 ID=SRX360015;Name=MYNN%20(@%20LoVo);Title=GSM1239583:%20batch5%20chrom1%20LoVo%20MYNN%20Rabbit%20FailedQC%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Digestive%20tract;
source_name=LoVo;cell%20line=LoVo;cell%20type=colon%20adenocarcinoma;hgn=MYNN;antibody=Abcam%20:%20ab66273;control%20sample=batch5_chrom1_LoVo_IgG_Rabbit;qc%20successful=FailedQC;fraction%20of%20peaks%20close%20to%20tss=0.060241;lowest%20e-value%20for%20a%20high%20complexity%20de%20novo%20motif=1; 161 . 142967411 142967863 0,164,255
chr1 149035126 149035650 ID=SRX360015;Name=MYNN%20(@%20LoVo);Title=GSM1239583:%20batch5%20chrom1%20LoVo%20MYNN%20Rabbit%20FailedQC%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Digestive%20tract;
source_name=LoVo;cell%20line=LoVo;cell%20type=colon%20adenocarcinoma;hgn=MYNN;antibody=Abcam%20:%20ab66273;control%20sample=batch5_chrom1_LoVo_IgG_Rabbit;qc%20successful=FailedQC;fraction%20of%20peaks%20close%20to%20tss=0.060241;lowest%20e-value%20for%20a%20high%20complexity%20de%20novo%20motif=1; 358 . 149035126 149035650 0,255,144
chr1 224200147 224200538 ID=SRX360015;Name=MYNN%20(@%20LoVo);Title=GSM1239583:%20batch5%20chrom1%20LoVo%20MYNN%20Rabbit%20FailedQC%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Digestive%20tract;
source_name=LoVo;cell%20line=LoVo;cell%20type=colon%20adenocarcinoma;hgn=MYNN;antibody=Abcam%20:%20ab66273;control%20sample=batch5_chrom1_LoVo_IgG_Rabbit;qc%20successful=FailedQC;fraction%20of%20peaks%20close%20to%20tss=0.060241;lowest%20e-value%20for%20a%20high%20complexity%20de%20novo%20motif=1; 221 . 224200147 224200538 0,225,255
chr1 249239904 249240525 ID=SRX360015;Name=MYNN%20(@%20LoVo);Title=GSM1239583:%20batch5%20chrom1%20LoVo%20MYNN%20Rabbit%20FailedQC%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Digestive%20tract;
source_name=LoVo;cell%20line=LoVo;cell%20type=colon%20adenocarcinoma;hgn=MYNN;antibody=Abcam%20:%20ab66273;control%20sample=batch5_chrom1_LoVo_IgG_Rabbit;qc%20successful=FailedQC;fraction%20of%20peaks%20close%20to%20tss=0.060241;lowest%20e-value%20for%20a%20high%20complexity%20de%20novo%20motif=1; 153 . 249239904 249240525 0,156,255
chr10 38871897 38872185 ID=SRX360015;Name=MYNN%20(@%20LoVo);Title=GSM1239583:%20batch5%20chrom1%20LoVo%20MYNN%20Rabbit%20FailedQC%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Digestive%20tract;
source_name=LoVo;cell%20line=LoVo;cell%20type=colon%20adenocarcinoma;hgn=MYNN;antibody=Abcam%20:%20ab66273;control%20sample=batch5_chrom1_LoVo_IgG_Rabbit;qc%20successful=FailedQC;fraction%20of%20peaks%20close%20to%20tss=0.060241;lowest%20e-value%20for%20a%20high%20complexity%20de%20novo%20motif=1; 200 . 38871897 38872185 0,204,255
chr10 38881530 38882226 ID=SRX360015;Name=MYNN%20(@%20LoVo);Title=GSM1239583:%20batch5%20chrom1%20LoVo%20MYNN%20Rabbit%20FailedQC%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Digestive%20tract;
source_name=LoVo;cell%20line=LoVo;cell%20type=colon%20adenocarcinoma;hgn=MYNN;antibody=Abcam%20:%20ab66273;control%20sample=batch5_chrom1_LoVo_IgG_Rabbit;qc%20successful=FailedQC;fraction%20of%20peaks%20close%20to%20tss=0.060241;lowest%20e-value%20for%20a%20high%20complexity%20de%20novo%20motif=1; 234 . 38881530 38882226 0,238,255
chr10 38888461 38888739 ID=SRX360015;Name=MYNN%20(@%20LoVo);Title=GSM1239583:%20batch5%20chrom1%20LoVo%20MYNN%20Rabbit%20FailedQC%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Digestive%20tract;
source_name=LoVo;cell%20line=LoVo;cell%20type=colon%20adenocarcinoma;hgn=MYNN;antibody=Abcam%20:%20ab66273;control%20sample=batch5_chrom1_LoVo_IgG_Rabbit;qc%20successful=FailedQC;fraction%20of%20peaks%20close%20to%20tss=0.060241;lowest%20e-value%20for%20a%20high%20complexity%20de%20novo%20motif=1; 133 . 38888461 38888739 0,135,255
chr10 42356338 42356759 ID=SRX360015;Name=MYNN%20(@%20LoVo);Title=GSM1239583:%20batch5%20chrom1%20LoVo%20MYNN%20Rabbit%20FailedQC%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Digestive%20tract;
source_name=LoVo;cell%20line=LoVo;cell%20type=colon%20adenocarcinoma;hgn=MYNN;antibody=Abcam%20:%20ab66273;control%20sample=batch5_chrom1_LoVo_IgG_Rabbit;qc%20successful=FailedQC;fraction%20of%20peaks%20close%20to%20tss=0.060241;lowest%20e-value%20for%20a%20high%20complexity%20de%20novo%20motif=1; 93 . 42356338 42356759 0,94,255
chr10 42384926 42385685 ID=SRX360015;Name=MYNN%20(@%20LoVo);Title=GSM1239583:%20batch5%20chrom1%20LoVo%20MYNN%20Rabbit%20FailedQC%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Digestive%20tract;
source_name=LoVo;cell%20line=LoVo;cell%20type=colon%20adenocarcinoma;hgn=MYNN;antibody=Abcam%20:%20ab66273;control%20sample=batch5_chrom1_LoVo_IgG_Rabbit;qc%20successful=FailedQC;fraction%20of%20peaks%20close%20to%20tss=0.060241;lowest%20e-value%20for%20a%20high%20complexity%20de%20novo%20motif=1; 353 . 42384926 42385685 0,255,149
chr10 42395911 42396334 ID=SRX360015;Name=MYNN%20(@%20LoVo);Title=GSM1239583:%20batch5%20chrom1%20LoVo%20MYNN%20Rabbit%20FailedQC%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Digestive%20tract;
source_name=LoVo;cell%20line=LoVo;cell%20type=colon%20adenocarcinoma;hgn=MYNN;antibody=Abcam%20:%20ab66273;control%20sample=batch5_chrom1_LoVo_IgG_Rabbit;qc%20successful=FailedQC;fraction%20of%20peaks%20close%20to%20tss=0.060241;lowest%20e-value%20for%20a%20high%20complexity%20de%20novo%20motif=1; 203 . 42395911 42396334 0,207,255
chr10 42400332 42400666 ID=SRX360015;Name=MYNN%20(@%20LoVo);Title=GSM1239583:%20batch5%20chrom1%20LoVo%20MYNN%20Rabbit%20FailedQC%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Digestive%20tract;
source_name=LoVo;cell%20line=LoVo;cell%20type=colon%20adenocarcinoma;hgn=MYNN;antibody=Abcam%20:%20ab66273;control%20sample=batch5_chrom1_LoVo_IgG_Rabbit;qc%20successful=FailedQC;fraction%20of%20peaks%20close%20to%20tss=0.060241;lowest%20e-value%20for%20a%20high%20complexity%20de%20novo%20motif=1; 232 . 42400332 42400666 0,236,255
chr10 42409158 42409520 ID=SRX360015;Name=MYNN%20(@%20LoVo);Title=GSM1239583:%20batch5%20chrom1%20LoVo%20MYNN%20Rabbit%20FailedQC%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Digestive%20tract;
source_name=LoVo;cell%20line=LoVo;cell%20type=colon%20adenocarcinoma;hgn=MYNN;antibody=Abcam%20:%20ab66273;control%20sample=batch5_chrom1_LoVo_IgG_Rabbit;qc%20successful=FailedQC;fraction%20of%20peaks%20close%20to%20tss=0.060241;lowest%20e-value%20for%20a%20high%20complexity%20de%20novo%20motif=1; 130 . 42409158 42409520 0,132,255
chr10 42527774 42528138 ID=SRX360015;Name=MYNN%20(@%20LoVo);Title=GSM1239583:%20batch5%20chrom1%20LoVo%20MYNN%20Rabbit%20FailedQC%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Digestive%20tract;
source_name=LoVo;cell%20line=LoVo;cell%20type=colon%20adenocarcinoma;hgn=MYNN;antibody=Abcam%20:%20ab66273;control%20sample=batch5_chrom1_LoVo_IgG_Rabbit;qc%20successful=FailedQC;fraction%20of%20peaks%20close%20to%20tss=0.060241;lowest%20e-value%20for%20a%20high%20complexity%20de%20novo%20motif=1; 129 . 42527774 42528138 0,131,255
chr10 42529208 42529868 ID=SRX360015;Name=MYNN%20(@%20LoVo);Title=GSM1239583:%20batch5%20chrom1%20LoVo%20MYNN%20Rabbit%20FailedQC%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Digestive%20tract;
source_name=LoVo;cell%20line=LoVo;cell%20type=colon%20adenocarcinoma;hgn=MYNN;antibody=Abcam%20:%20ab66273;control%20sample=batch5_chrom1_LoVo_IgG_Rabbit;qc%20successful=FailedQC;fraction%20of%20peaks%20close%20to%20tss=0.060241;lowest%20e-value%20for%20a%20high%20complexity%20de%20novo%20motif=1; 299 . 42529208 42529868 0,255,205
chr10 42545869 42546319 ID=SRX360015;Name=MYNN%20(@%20LoVo);Title=GSM1239583:%20batch5%20chrom1%20LoVo%20MYNN%20Rabbit%20FailedQC%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Digestive%20tract;
source_name=LoVo;cell%20line=LoVo;cell%20type=colon%20adenocarcinoma;hgn=MYNN;antibody=Abcam%20:%20ab66273;control%20sample=batch5_chrom1_LoVo_IgG_Rabbit;qc%20successful=FailedQC;fraction%20of%20peaks%20close%20to%20tss=0.060241;lowest%20e-value%20for%20a%20high%20complexity%20de%20novo%20motif=1; 215 . 42545869 42546319 0,219,255
chr10 42596708 42597389 ID=SRX360015;Name=MYNN%20(@%20LoVo);Title=GSM1239583:%20batch5%20chrom1%20LoVo%20MYNN%20Rabbit%20FailedQC%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Digestive%20tract;
source_name=LoVo;cell%20line=LoVo;cell%20type=colon%20adenocarcinoma;hgn=MYNN;antibody=Abcam%20:%20ab66273;control%20sample=batch5_chrom1_LoVo_IgG_Rabbit;qc%20successful=FailedQC;fraction%20of%20peaks%20close%20to%20tss=0.060241;lowest%20e-value%20for%20a%20high%20complexity%20de%20novo%20motif=1; 713 . 42596708 42597389 217,255,0
chr10 42597491 42598381 ID=SRX360015;Name=MYNN%20(@%20LoVo);Title=GSM1239583:%20batch5%20chrom1%20LoVo%20MYNN%20Rabbit%20FailedQC%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Digestive%20tract;
source_name=LoVo;cell%20line=LoVo;cell%20type=colon%20adenocarcinoma;hgn=MYNN;antibody=Abcam%20:%20ab66273;control%20sample=batch5_chrom1_LoVo_IgG_Rabbit;qc%20successful=FailedQC;fraction%20of%20peaks%20close%20to%20tss=0.060241;lowest%20e-value%20for%20a%20high%20complexity%20de%20novo%20motif=1; 464 . 42597491 42598381 0,255,36
chr10 42598882 42600453 ID=SRX360015;Name=MYNN%20(@%20LoVo);Title=GSM1239583:%20batch5%20chrom1%20LoVo%20MYNN%20Rabbit%20FailedQC%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Digestive%20tract;
source_name=LoVo;cell%20line=LoVo;cell%20type=colon%20adenocarcinoma;hgn=MYNN;antibody=Abcam%20:%20ab66273;control%20sample=batch5_chrom1_LoVo_IgG_Rabbit;qc%20successful=FailedQC;fraction%20of%20peaks%20close%20to%20tss=0.060241;lowest%20e-value%20for%20a%20high%20complexity%20de%20novo%20motif=1; 721 . 42598882 42600453 225,255,0
chr10 42799739 42800022 ID=SRX360015;Name=MYNN%20(@%20LoVo);Title=GSM1239583:%20batch5%20chrom1%20LoVo%20MYNN%20Rabbit%20FailedQC%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Digestive%20tract;
source_name=LoVo;cell%20line=LoVo;cell%20type=colon%20adenocarcinoma;hgn=MYNN;antibody=Abcam%20:%20ab66273;control%20sample=batch5_chrom1_LoVo_IgG_Rabbit;qc%20successful=FailedQC;fraction%20of%20peaks%20close%20to%20tss=0.060241;lowest%20e-value%20for%20a%20high%20complexity%20de%20novo%20motif=1; 140 . 42799739 42800022 0,142,255
chr10 119940959 119941461 ID=SRX360015;Name=MYNN%20(@%20LoVo);Title=GSM1239583:%20batch5%20chrom1%20LoVo%20MYNN%20Rabbit%20FailedQC%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Digestive%20tract;
source_name=LoVo;cell%20line=LoVo;cell%20type=colon%20adenocarcinoma;hgn=MYNN;antibody=Abcam%20:%20ab66273;control%20sample=batch5_chrom1_LoVo_IgG_Rabbit;qc%20successful=FailedQC;fraction%20of%20peaks%20close%20to%20tss=0.060241;lowest%20e-value%20for%20a%20high%20complexity%20de%20novo%20motif=1; 236 . 119940959 119941461 0,240,255
chr10 130262539 130263101 ID=SRX360015;Name=MYNN%20(@%20LoVo);Title=GSM1239583:%20batch5%20chrom1%20LoVo%20MYNN%20Rabbit%20FailedQC%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Digestive%20tract;
source_name=LoVo;cell%20line=LoVo;cell%20type=colon%20adenocarcinoma;hgn=MYNN;antibody=Abcam%20:%20ab66273;control%20sample=batch5_chrom1_LoVo_IgG_Rabbit;qc%20successful=FailedQC;fraction%20of%20peaks%20close%20to%20tss=0.060241;lowest%20e-value%20for%20a%20high%20complexity%20de%20novo%20motif=1; 843 . 130262539 130263101 255,160,0
chr11 3675404 3676023 ID=SRX360015;Name=MYNN%20(@%20LoVo);Title=GSM1239583:%20batch5%20chrom1%20LoVo%20MYNN%20Rabbit%20FailedQC%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Digestive%20tract;
source_name=LoVo;cell%20line=LoVo;cell%20type=colon%20adenocarcinoma;hgn=MYNN;antibody=Abcam%20:%20ab66273;control%20sample=batch5_chrom1_LoVo_IgG_Rabbit;qc%20successful=FailedQC;fraction%20of%20peaks%20close%20to%20tss=0.060241;lowest%20e-value%20for%20a%20high%20complexity%20de%20novo%20motif=1; 143 . 3675404 3676023 0,145,255
chr11 51582718 51583023 ID=SRX360015;Name=MYNN%20(@%20LoVo);Title=GSM1239583:%20batch5%20chrom1%20LoVo%20MYNN%20Rabbit%20FailedQC%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Digestive%20tract;
source_name=LoVo;cell%20line=LoVo;cell%20type=colon%20adenocarcinoma;hgn=MYNN;antibody=Abcam%20:%20ab66273;control%20sample=batch5_chrom1_LoVo_IgG_Rabbit;qc%20successful=FailedQC;fraction%20of%20peaks%20close%20to%20tss=0.060241;lowest%20e-value%20for%20a%20high%20complexity%20de%20novo%20motif=1; 169 . 51582718 51583023 0,172,255
chr11 51586764 51587090 ID=SRX360015;Name=MYNN%20(@%20LoVo);Title=GSM1239583:%20batch5%20chrom1%20LoVo%20MYNN%20Rabbit%20FailedQC%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Digestive%20tract;
source_name=LoVo;cell%20line=LoVo;cell%20type=colon%20adenocarcinoma;hgn=MYNN;antibody=Abcam%20:%20ab66273;control%20sample=batch5_chrom1_LoVo_IgG_Rabbit;qc%20successful=FailedQC;fraction%20of%20peaks%20close%20to%20tss=0.060241;lowest%20e-value%20for%20a%20high%20complexity%20de%20novo%20motif=1; 173 . 51586764 51587090 0,176,255
chr11 51588794 51589164 ID=SRX360015;Name=MYNN%20(@%20LoVo);Title=GSM1239583:%20batch5%20chrom1%20LoVo%20MYNN%20Rabbit%20FailedQC%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Digestive%20tract;
source_name=LoVo;cell%20line=LoVo;cell%20type=colon%20adenocarcinoma;hgn=MYNN;antibody=Abcam%20:%20ab66273;control%20sample=batch5_chrom1_LoVo_IgG_Rabbit;qc%20successful=FailedQC;fraction%20of%20peaks%20close%20to%20tss=0.060241;lowest%20e-value%20for%20a%20high%20complexity%20de%20novo%20motif=1; 193 . 51588794 51589164 0,196,255
chr11 51590863 51591340 ID=SRX360015;Name=MYNN%20(@%20LoVo);Title=GSM1239583:%20batch5%20chrom1%20LoVo%20MYNN%20Rabbit%20FailedQC%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Digestive%20tract;
source_name=LoVo;cell%20line=LoVo;cell%20type=colon%20adenocarcinoma;hgn=MYNN;antibody=Abcam%20:%20ab66273;control%20sample=batch5_chrom1_LoVo_IgG_Rabbit;qc%20successful=FailedQC;fraction%20of%20peaks%20close%20to%20tss=0.060241;lowest%20e-value%20for%20a%20high%20complexity%20de%20novo%20motif=1; 244 . 51590863 51591340 0,248,255
chr11 55026176 55026528 ID=SRX360015;Name=MYNN%20(@%20LoVo);Title=GSM1239583:%20batch5%20chrom1%20LoVo%20MYNN%20Rabbit%20FailedQC%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Digestive%20tract;
source_name=LoVo;cell%20line=LoVo;cell%20type=colon%20adenocarcinoma;hgn=MYNN;antibody=Abcam%20:%20ab66273;control%20sample=batch5_chrom1_LoVo_IgG_Rabbit;qc%20successful=FailedQC;fraction%20of%20peaks%20close%20to%20tss=0.060241;lowest%20e-value%20for%20a%20high%20complexity%20de%20novo%20motif=1; 248 . 55026176 55026528 0,252,255
chr12 95461 95767 ID=SRX360015;Name=MYNN%20(@%20LoVo);Title=GSM1239583:%20batch5%20chrom1%20LoVo%20MYNN%20Rabbit%20FailedQC%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Digestive%20tract;
source_name=LoVo;cell%20line=LoVo;cell%20type=colon%20adenocarcinoma;hgn=MYNN;antibody=Abcam%20:%20ab66273;control%20sample=batch5_chrom1_LoVo_IgG_Rabbit;qc%20successful=FailedQC;fraction%20of%20peaks%20close%20to%20tss=0.060241;lowest%20e-value%20for%20a%20high%20complexity%20de%20novo%20motif=1; 170 . 95461 95767 0,173,255
chr12 2364893 2365388 ID=SRX360015;Name=MYNN%20(@%20LoVo);Title=GSM1239583:%20batch5%20chrom1%20LoVo%20MYNN%20Rabbit%20FailedQC%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Digestive%20tract;
source_name=LoVo;cell%20line=LoVo;cell%20type=colon%20adenocarcinoma;hgn=MYNN;antibody=Abcam%20:%20ab66273;control%20sample=batch5_chrom1_LoVo_IgG_Rabbit;qc%20successful=FailedQC;fraction%20of%20peaks%20close%20to%20tss=0.060241;lowest%20e-value%20for%20a%20high%20complexity%20de%20novo%20motif=1; 223 . 2364893 2365388 0,227,255
chr12 38028862 38029195 ID=SRX360015;Name=MYNN%20(@%20LoVo);Title=GSM1239583:%20batch5%20chrom1%20LoVo%20MYNN%20Rabbit%20FailedQC%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Digestive%20tract;
source_name=LoVo;cell%20line=LoVo;cell%20type=colon%20adenocarcinoma;hgn=MYNN;antibody=Abcam%20:%20ab66273;control%20sample=batch5_chrom1_LoVo_IgG_Rabbit;qc%20successful=FailedQC;fraction%20of%20peaks%20close%20to%20tss=0.060241;lowest%20e-value%20for%20a%20high%20complexity%20de%20novo%20motif=1; 199 . 38028862 38029195 0,202,255
chr12 132061265 132061951 ID=SRX360015;Name=MYNN%20(@%20LoVo);Title=GSM1239583:%20batch5%20chrom1%20LoVo%20MYNN%20Rabbit%20FailedQC%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Digestive%20tract;
source_name=LoVo;cell%20line=LoVo;cell%20type=colon%20adenocarcinoma;hgn=MYNN;antibody=Abcam%20:%20ab66273;control%20sample=batch5_chrom1_LoVo_IgG_Rabbit;qc%20successful=FailedQC;fraction%20of%20peaks%20close%20to%20tss=0.060241;lowest%20e-value%20for%20a%20high%20complexity%20de%20novo%20motif=1; 284 . 132061265 132061951 0,255,220
chr12 132072872 132073285 ID=SRX360015;Name=MYNN%20(@%20LoVo);Title=GSM1239583:%20batch5%20chrom1%20LoVo%20MYNN%20Rabbit%20FailedQC%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Digestive%20tract;
source_name=LoVo;cell%20line=LoVo;cell%20type=colon%20adenocarcinoma;hgn=MYNN;antibody=Abcam%20:%20ab66273;control%20sample=batch5_chrom1_LoVo_IgG_Rabbit;qc%20successful=FailedQC;fraction%20of%20peaks%20close%20to%20tss=0.060241;lowest%20e-value%20for%20a%20high%20complexity%20de%20novo%20motif=1; 258 . 132072872 132073285 0,255,246
chr12 133841468 133842010 ID=SRX360015;Name=MYNN%20(@%20LoVo);Title=GSM1239583:%20batch5%20chrom1%20LoVo%20MYNN%20Rabbit%20FailedQC%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Digestive%20tract;
source_name=LoVo;cell%20line=LoVo;cell%20type=colon%20adenocarcinoma;hgn=MYNN;antibody=Abcam%20:%20ab66273;control%20sample=batch5_chrom1_LoVo_IgG_Rabbit;qc%20successful=FailedQC;fraction%20of%20peaks%20close%20to%20tss=0.060241;lowest%20e-value%20for%20a%20high%20complexity%20de%20novo%20motif=1; 339 . 133841468 133842010 0,255,164
chr15 102521087 102521377 ID=SRX360015;Name=MYNN%20(@%20LoVo);Title=GSM1239583:%20batch5%20chrom1%20LoVo%20MYNN%20Rabbit%20FailedQC%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Digestive%20tract;
source_name=LoVo;cell%20line=LoVo;cell%20type=colon%20adenocarcinoma;hgn=MYNN;antibody=Abcam%20:%20ab66273;control%20sample=batch5_chrom1_LoVo_IgG_Rabbit;qc%20successful=FailedQC;fraction%20of%20peaks%20close%20to%20tss=0.060241;lowest%20e-value%20for%20a%20high%20complexity%20de%20novo%20motif=1; 98 . 102521087 102521377 0,99,255
chr16 33866345 33866747 ID=SRX360015;Name=MYNN%20(@%20LoVo);Title=GSM1239583:%20batch5%20chrom1%20LoVo%20MYNN%20Rabbit%20FailedQC%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Digestive%20tract;
source_name=LoVo;cell%20line=LoVo;cell%20type=colon%20adenocarcinoma;hgn=MYNN;antibody=Abcam%20:%20ab66273;control%20sample=batch5_chrom1_LoVo_IgG_Rabbit;qc%20successful=FailedQC;fraction%20of%20peaks%20close%20to%20tss=0.060241;lowest%20e-value%20for%20a%20high%20complexity%20de%20novo%20motif=1; 183 . 33866345 33866747 0,186,255
chr16 33887659 33887953 ID=SRX360015;Name=MYNN%20(@%20LoVo);Title=GSM1239583:%20batch5%20chrom1%20LoVo%20MYNN%20Rabbit%20FailedQC%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Digestive%20tract;
source_name=LoVo;cell%20line=LoVo;cell%20type=colon%20adenocarcinoma;hgn=MYNN;antibody=Abcam%20:%20ab66273;control%20sample=batch5_chrom1_LoVo_IgG_Rabbit;qc%20successful=FailedQC;fraction%20of%20peaks%20close%20to%20tss=0.060241;lowest%20e-value%20for%20a%20high%20complexity%20de%20novo%20motif=1; 160 . 33887659 33887953 0,163,255
chr16 33899632 33899957 ID=SRX360015;Name=MYNN%20(@%20LoVo);Title=GSM1239583:%20batch5%20chrom1%20LoVo%20MYNN%20Rabbit%20FailedQC%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Digestive%20tract;
source_name=LoVo;cell%20line=LoVo;cell%20type=colon%20adenocarcinoma;hgn=MYNN;antibody=Abcam%20:%20ab66273;control%20sample=batch5_chrom1_LoVo_IgG_Rabbit;qc%20successful=FailedQC;fraction%20of%20peaks%20close%20to%20tss=0.060241;lowest%20e-value%20for%20a%20high%20complexity%20de%20novo%20motif=1; 128 . 33899632 33899957 0,130,255
chr16 46406480 46406959 ID=SRX360015;Name=MYNN%20(@%20LoVo);Title=GSM1239583:%20batch5%20chrom1%20LoVo%20MYNN%20Rabbit%20FailedQC%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Digestive%20tract;
source_name=LoVo;cell%20line=LoVo;cell%20type=colon%20adenocarcinoma;hgn=MYNN;antibody=Abcam%20:%20ab66273;control%20sample=batch5_chrom1_LoVo_IgG_Rabbit;qc%20successful=FailedQC;fraction%20of%20peaks%20close%20to%20tss=0.060241;lowest%20e-value%20for%20a%20high%20complexity%20de%20novo%20motif=1; 157 . 46406480 46406959 0,160,255
chr16 46412851 46413540 ID=SRX360015;Name=MYNN%20(@%20LoVo);Title=GSM1239583:%20batch5%20chrom1%20LoVo%20MYNN%20Rabbit%20FailedQC%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Digestive%20tract;
source_name=LoVo;cell%20line=LoVo;cell%20type=colon%20adenocarcinoma;hgn=MYNN;antibody=Abcam%20:%20ab66273;control%20sample=batch5_chrom1_LoVo_IgG_Rabbit;qc%20successful=FailedQC;fraction%20of%20peaks%20close%20to%20tss=0.060241;lowest%20e-value%20for%20a%20high%20complexity%20de%20novo%20motif=1; 293 . 46412851 46413540 0,255,211
chr16 46414168 46414480 ID=SRX360015;Name=MYNN%20(@%20LoVo);Title=GSM1239583:%20batch5%20chrom1%20LoVo%20MYNN%20Rabbit%20FailedQC%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Digestive%20tract;
source_name=LoVo;cell%20line=LoVo;cell%20type=colon%20adenocarcinoma;hgn=MYNN;antibody=Abcam%20:%20ab66273;control%20sample=batch5_chrom1_LoVo_IgG_Rabbit;qc%20successful=FailedQC;fraction%20of%20peaks%20close%20to%20tss=0.060241;lowest%20e-value%20for%20a%20high%20complexity%20de%20novo%20motif=1; 115 . 46414168 46414480 0,117,255
chr16 46423757 46424116 ID=SRX360015;Name=MYNN%20(@%20LoVo);Title=GSM1239583:%20batch5%20chrom1%20LoVo%20MYNN%20Rabbit%20FailedQC%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Digestive%20tract;
source_name=LoVo;cell%20line=LoVo;cell%20type=colon%20adenocarcinoma;hgn=MYNN;antibody=Abcam%20:%20ab66273;control%20sample=batch5_chrom1_LoVo_IgG_Rabbit;qc%20successful=FailedQC;fraction%20of%20peaks%20close%20to%20tss=0.060241;lowest%20e-value%20for%20a%20high%20complexity%20de%20novo%20motif=1; 93 . 46423757 46424116 0,94,255
chr16 46428278 46428821 ID=SRX360015;Name=MYNN%20(@%20LoVo);Title=GSM1239583:%20batch5%20chrom1%20LoVo%20MYNN%20Rabbit%20FailedQC%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Digestive%20tract;
source_name=LoVo;cell%20line=LoVo;cell%20type=colon%20adenocarcinoma;hgn=MYNN;antibody=Abcam%20:%20ab66273;control%20sample=batch5_chrom1_LoVo_IgG_Rabbit;qc%20successful=FailedQC;fraction%20of%20peaks%20close%20to%20tss=0.060241;lowest%20e-value%20for%20a%20high%20complexity%20de%20novo%20motif=1; 130 . 46428278 46428821 0,132,255
chr16 46432257 46432843 ID=SRX360015;Name=MYNN%20(@%20LoVo);Title=GSM1239583:%20batch5%20chrom1%20LoVo%20MYNN%20Rabbit%20FailedQC%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Digestive%20tract;
source_name=LoVo;cell%20line=LoVo;cell%20type=colon%20adenocarcinoma;hgn=MYNN;antibody=Abcam%20:%20ab66273;control%20sample=batch5_chrom1_LoVo_IgG_Rabbit;qc%20successful=FailedQC;fraction%20of%20peaks%20close%20to%20tss=0.060241;lowest%20e-value%20for%20a%20high%20complexity%20de%20novo%20motif=1; 236 . 46432257 46432843 0,240,255
chr16 46433735 46434460 ID=SRX360015;Name=MYNN%20(@%20LoVo);Title=GSM1239583:%20batch5%20chrom1%20LoVo%20MYNN%20Rabbit%20FailedQC%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Digestive%20tract;
source_name=LoVo;cell%20line=LoVo;cell%20type=colon%20adenocarcinoma;hgn=MYNN;antibody=Abcam%20:%20ab66273;control%20sample=batch5_chrom1_LoVo_IgG_Rabbit;qc%20successful=FailedQC;fraction%20of%20peaks%20close%20to%20tss=0.060241;lowest%20e-value%20for%20a%20high%20complexity%20de%20novo%20motif=1; 169 . 46433735 46434460 0,172,255
chr16 46434908 46435537 ID=SRX360015;Name=MYNN%20(@%20LoVo);Title=GSM1239583:%20batch5%20chrom1%20LoVo%20MYNN%20Rabbit%20FailedQC%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Digestive%20tract;
source_name=LoVo;cell%20line=LoVo;cell%20type=colon%20adenocarcinoma;hgn=MYNN;antibody=Abcam%20:%20ab66273;control%20sample=batch5_chrom1_LoVo_IgG_Rabbit;qc%20successful=FailedQC;fraction%20of%20peaks%20close%20to%20tss=0.060241;lowest%20e-value%20for%20a%20high%20complexity%20de%20novo%20motif=1; 395 . 46434908 46435537 0,255,107
chr17 25263625 25263960 ID=SRX360015;Name=MYNN%20(@%20LoVo);Title=GSM1239583:%20batch5%20chrom1%20LoVo%20MYNN%20Rabbit%20FailedQC%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Digestive%20tract;
source_name=LoVo;cell%20line=LoVo;cell%20type=colon%20adenocarcinoma;hgn=MYNN;antibody=Abcam%20:%20ab66273;control%20sample=batch5_chrom1_LoVo_IgG_Rabbit;qc%20successful=FailedQC;fraction%20of%20peaks%20close%20to%20tss=0.060241;lowest%20e-value%20for%20a%20high%20complexity%20de%20novo%20motif=1; 158 . 25263625 25263960 0,161,255
chr17 25265131 25265414 ID=SRX360015;Name=MYNN%20(@%20LoVo);Title=GSM1239583:%20batch5%20chrom1%20LoVo%20MYNN%20Rabbit%20FailedQC%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Digestive%20tract;
source_name=LoVo;cell%20line=LoVo;cell%20type=colon%20adenocarcinoma;hgn=MYNN;antibody=Abcam%20:%20ab66273;control%20sample=batch5_chrom1_LoVo_IgG_Rabbit;qc%20successful=FailedQC;fraction%20of%20peaks%20close%20to%20tss=0.060241;lowest%20e-value%20for%20a%20high%20complexity%20de%20novo%20motif=1; 118 . 25265131 25265414 0,120,255
chr18 10061 10440 ID=SRX360015;Name=MYNN%20(@%20LoVo);Title=GSM1239583:%20batch5%20chrom1%20LoVo%20MYNN%20Rabbit%20FailedQC%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Digestive%20tract;
source_name=LoVo;cell%20line=LoVo;cell%20type=colon%20adenocarcinoma;hgn=MYNN;antibody=Abcam%20:%20ab66273;control%20sample=batch5_chrom1_LoVo_IgG_Rabbit;qc%20successful=FailedQC;fraction%20of%20peaks%20close%20to%20tss=0.060241;lowest%20e-value%20for%20a%20high%20complexity%20de%20novo%20motif=1; 157 . 10061 10440 0,160,255
chr18 107964 108471 ID=SRX360015;Name=MYNN%20(@%20LoVo);Title=GSM1239583:%20batch5%20chrom1%20LoVo%20MYNN%20Rabbit%20FailedQC%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Digestive%20tract;
source_name=LoVo;cell%20line=LoVo;cell%20type=colon%20adenocarcinoma;hgn=MYNN;antibody=Abcam%20:%20ab66273;control%20sample=batch5_chrom1_LoVo_IgG_Rabbit;qc%20successful=FailedQC;fraction%20of%20peaks%20close%20to%20tss=0.060241;lowest%20e-value%20for%20a%20high%20complexity%20de%20novo%20motif=1; 217 . 107964 108471 0,221,255
chr18 18512844 18513162 ID=SRX360015;Name=MYNN%20(@%20LoVo);Title=GSM1239583:%20batch5%20chrom1%20LoVo%20MYNN%20Rabbit%20FailedQC%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Digestive%20tract;
source_name=LoVo;cell%20line=LoVo;cell%20type=colon%20adenocarcinoma;hgn=MYNN;antibody=Abcam%20:%20ab66273;control%20sample=batch5_chrom1_LoVo_IgG_Rabbit;qc%20successful=FailedQC;fraction%20of%20peaks%20close%20to%20tss=0.060241;lowest%20e-value%20for%20a%20high%20complexity%20de%20novo%20motif=1; 172 . 18512844 18513162 0,175,255
chr18 18518845 18519642 ID=SRX360015;Name=MYNN%20(@%20LoVo);Title=GSM1239583:%20batch5%20chrom1%20LoVo%20MYNN%20Rabbit%20FailedQC%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Digestive%20tract;
source_name=LoVo;cell%20line=LoVo;cell%20type=colon%20adenocarcinoma;hgn=MYNN;antibody=Abcam%20:%20ab66273;control%20sample=batch5_chrom1_LoVo_IgG_Rabbit;qc%20successful=FailedQC;fraction%20of%20peaks%20close%20to%20tss=0.060241;lowest%20e-value%20for%20a%20high%20complexity%20de%20novo%20motif=1; 269 . 18518845 18519642 0,255,235
chr18 44126245 44126637 ID=SRX360015;Name=MYNN%20(@%20LoVo);Title=GSM1239583:%20batch5%20chrom1%20LoVo%20MYNN%20Rabbit%20FailedQC%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Digestive%20tract;
source_name=LoVo;cell%20line=LoVo;cell%20type=colon%20adenocarcinoma;hgn=MYNN;antibody=Abcam%20:%20ab66273;control%20sample=batch5_chrom1_LoVo_IgG_Rabbit;qc%20successful=FailedQC;fraction%20of%20peaks%20close%20to%20tss=0.060241;lowest%20e-value%20for%20a%20high%20complexity%20de%20novo%20motif=1; 288 . 44126245 44126637 0,255,216
chr18 50318960 50319435 ID=SRX360015;Name=MYNN%20(@%20LoVo);Title=GSM1239583:%20batch5%20chrom1%20LoVo%20MYNN%20Rabbit%20FailedQC%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Digestive%20tract;
source_name=LoVo;cell%20line=LoVo;cell%20type=colon%20adenocarcinoma;hgn=MYNN;antibody=Abcam%20:%20ab66273;control%20sample=batch5_chrom1_LoVo_IgG_Rabbit;qc%20successful=FailedQC;fraction%20of%20peaks%20close%20to%20tss=0.060241;lowest%20e-value%20for%20a%20high%20complexity%20de%20novo%20motif=1; 272 . 50318960 50319435 0,255,232
chr19 7515365 7515642 ID=SRX360015;Name=MYNN%20(@%20LoVo);Title=GSM1239583:%20batch5%20chrom1%20LoVo%20MYNN%20Rabbit%20FailedQC%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Digestive%20tract;
source_name=LoVo;cell%20line=LoVo;cell%20type=colon%20adenocarcinoma;hgn=MYNN;antibody=Abcam%20:%20ab66273;control%20sample=batch5_chrom1_LoVo_IgG_Rabbit;qc%20successful=FailedQC;fraction%20of%20peaks%20close%20to%20tss=0.060241;lowest%20e-value%20for%20a%20high%20complexity%20de%20novo%20motif=1; 100 . 7515365 7515642 0,102,255
chr19 27731879 27733470 ID=SRX360015;Name=MYNN%20(@%20LoVo);Title=GSM1239583:%20batch5%20chrom1%20LoVo%20MYNN%20Rabbit%20FailedQC%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Digestive%20tract;
source_name=LoVo;cell%20line=LoVo;cell%20type=colon%20adenocarcinoma;hgn=MYNN;antibody=Abcam%20:%20ab66273;control%20sample=batch5_chrom1_LoVo_IgG_Rabbit;qc%20successful=FailedQC;fraction%20of%20peaks%20close%20to%20tss=0.060241;lowest%20e-value%20for%20a%20high%20complexity%20de%20novo%20motif=1; 634 . 27731879 27733470 136,255,0
chr19 27738243 27738902 ID=SRX360015;Name=MYNN%20(@%20LoVo);Title=GSM1239583:%20batch5%20chrom1%20LoVo%20MYNN%20Rabbit%20FailedQC%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Digestive%20tract;
source_name=LoVo;cell%20line=LoVo;cell%20type=colon%20adenocarcinoma;hgn=MYNN;antibody=Abcam%20:%20ab66273;control%20sample=batch5_chrom1_LoVo_IgG_Rabbit;qc%20successful=FailedQC;fraction%20of%20peaks%20close%20to%20tss=0.060241;lowest%20e-value%20for%20a%20high%20complexity%20de%20novo%20motif=1; 544 . 27738243 27738902 44,255,0
chr2 11093739 11094122 ID=SRX360015;Name=MYNN%20(@%20LoVo);Title=GSM1239583:%20batch5%20chrom1%20LoVo%20MYNN%20Rabbit%20FailedQC%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Digestive%20tract;
source_name=LoVo;cell%20line=LoVo;cell%20type=colon%20adenocarcinoma;hgn=MYNN;antibody=Abcam%20:%20ab66273;control%20sample=batch5_chrom1_LoVo_IgG_Rabbit;qc%20successful=FailedQC;fraction%20of%20peaks%20close%20to%20tss=0.060241;lowest%20e-value%20for%20a%20high%20complexity%20de%20novo%20motif=1; 90 . 11093739 11094122 0,91,255
chr2 33141192 33141510 ID=SRX360015;Name=MYNN%20(@%20LoVo);Title=GSM1239583:%20batch5%20chrom1%20LoVo%20MYNN%20Rabbit%20FailedQC%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Digestive%20tract;
source_name=LoVo;cell%20line=LoVo;cell%20type=colon%20adenocarcinoma;hgn=MYNN;antibody=Abcam%20:%20ab66273;control%20sample=batch5_chrom1_LoVo_IgG_Rabbit;qc%20successful=FailedQC;fraction%20of%20peaks%20close%20to%20tss=0.060241;lowest%20e-value%20for%20a%20high%20complexity%20de%20novo%20motif=1; 234 . 33141192 33141510 0,238,255
chr2 89878363 89878753 ID=SRX360015;Name=MYNN%20(@%20LoVo);Title=GSM1239583:%20batch5%20chrom1%20LoVo%20MYNN%20Rabbit%20FailedQC%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Digestive%20tract;
source_name=LoVo;cell%20line=LoVo;cell%20type=colon%20adenocarcinoma;hgn=MYNN;antibody=Abcam%20:%20ab66273;control%20sample=batch5_chrom1_LoVo_IgG_Rabbit;qc%20successful=FailedQC;fraction%20of%20peaks%20close%20to%20tss=0.060241;lowest%20e-value%20for%20a%20high%20complexity%20de%20novo%20motif=1; 174 . 89878363 89878753 0,177,255
chr2 89878899 89879406 ID=SRX360015;Name=MYNN%20(@%20LoVo);Title=GSM1239583:%20batch5%20chrom1%20LoVo%20MYNN%20Rabbit%20FailedQC%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Digestive%20tract;
source_name=LoVo;cell%20line=LoVo;cell%20type=colon%20adenocarcinoma;hgn=MYNN;antibody=Abcam%20:%20ab66273;control%20sample=batch5_chrom1_LoVo_IgG_Rabbit;qc%20successful=FailedQC;fraction%20of%20peaks%20close%20to%20tss=0.060241;lowest%20e-value%20for%20a%20high%20complexity%20de%20novo%20motif=1; 235 . 89878899 89879406 0,239,255
chr2 92268901 92269874 ID=SRX360015;Name=MYNN%20(@%20LoVo);Title=GSM1239583:%20batch5%20chrom1%20LoVo%20MYNN%20Rabbit%20FailedQC%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Digestive%20tract;
source_name=LoVo;cell%20line=LoVo;cell%20type=colon%20adenocarcinoma;hgn=MYNN;antibody=Abcam%20:%20ab66273;control%20sample=batch5_chrom1_LoVo_IgG_Rabbit;qc%20successful=FailedQC;fraction%20of%20peaks%20close%20to%20tss=0.060241;lowest%20e-value%20for%20a%20high%20complexity%20de%20novo%20motif=1; 497 . 92268901 92269874 0,255,3
chr2 92281224 92281578 ID=SRX360015;Name=MYNN%20(@%20LoVo);Title=GSM1239583:%20batch5%20chrom1%20LoVo%20MYNN%20Rabbit%20FailedQC%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Digestive%20tract;
source_name=LoVo;cell%20line=LoVo;cell%20type=colon%20adenocarcinoma;hgn=MYNN;antibody=Abcam%20:%20ab66273;control%20sample=batch5_chrom1_LoVo_IgG_Rabbit;qc%20successful=FailedQC;fraction%20of%20peaks%20close%20to%20tss=0.060241;lowest%20e-value%20for%20a%20high%20complexity%20de%20novo%20motif=1; 264 . 92281224 92281578 0,255,240
chr2 92290414 92291663 ID=SRX360015;Name=MYNN%20(@%20LoVo);Title=GSM1239583:%20batch5%20chrom1%20LoVo%20MYNN%20Rabbit%20FailedQC%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Digestive%20tract;
source_name=LoVo;cell%20line=LoVo;cell%20type=colon%20adenocarcinoma;hgn=MYNN;antibody=Abcam%20:%20ab66273;control%20sample=batch5_chrom1_LoVo_IgG_Rabbit;qc%20successful=FailedQC;fraction%20of%20peaks%20close%20to%20tss=0.060241;lowest%20e-value%20for%20a%20high%20complexity%20de%20novo%20motif=1; 320 . 92290414 92291663 0,255,183
chr2 92296519 92296797 ID=SRX360015;Name=MYNN%20(@%20LoVo);Title=GSM1239583:%20batch5%20chrom1%20LoVo%20MYNN%20Rabbit%20FailedQC%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Digestive%20tract;
source_name=LoVo;cell%20line=LoVo;cell%20type=colon%20adenocarcinoma;hgn=MYNN;antibody=Abcam%20:%20ab66273;control%20sample=batch5_chrom1_LoVo_IgG_Rabbit;qc%20successful=FailedQC;fraction%20of%20peaks%20close%20to%20tss=0.060241;lowest%20e-value%20for%20a%20high%20complexity%20de%20novo%20motif=1; 153 . 92296519 92296797 0,156,255
chr2 92297268 92297671 ID=SRX360015;Name=MYNN%20(@%20LoVo);Title=GSM1239583:%20batch5%20chrom1%20LoVo%20MYNN%20Rabbit%20FailedQC%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Digestive%20tract;
source_name=LoVo;cell%20line=LoVo;cell%20type=colon%20adenocarcinoma;hgn=MYNN;antibody=Abcam%20:%20ab66273;control%20sample=batch5_chrom1_LoVo_IgG_Rabbit;qc%20successful=FailedQC;fraction%20of%20peaks%20close%20to%20tss=0.060241;lowest%20e-value%20for%20a%20high%20complexity%20de%20novo%20motif=1; 147 . 92297268 92297671 0,149,255
chr2 109815627 109816384 ID=SRX360015;Name=MYNN%20(@%20LoVo);Title=GSM1239583:%20batch5%20chrom1%20LoVo%20MYNN%20Rabbit%20FailedQC%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Digestive%20tract;
source_name=LoVo;cell%20line=LoVo;cell%20type=colon%20adenocarcinoma;hgn=MYNN;antibody=Abcam%20:%20ab66273;control%20sample=batch5_chrom1_LoVo_IgG_Rabbit;qc%20successful=FailedQC;fraction%20of%20peaks%20close%20to%20tss=0.060241;lowest%20e-value%20for%20a%20high%20complexity%20de%20novo%20motif=1; 909 . 109815627 109816384 255,92,0
chr20 29829249 29829928 ID=SRX360015;Name=MYNN%20(@%20LoVo);Title=GSM1239583:%20batch5%20chrom1%20LoVo%20MYNN%20Rabbit%20FailedQC%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Digestive%20tract;
source_name=LoVo;cell%20line=LoVo;cell%20type=colon%20adenocarcinoma;hgn=MYNN;antibody=Abcam%20:%20ab66273;control%20sample=batch5_chrom1_LoVo_IgG_Rabbit;qc%20successful=FailedQC;fraction%20of%20peaks%20close%20to%20tss=0.060241;lowest%20e-value%20for%20a%20high%20complexity%20de%20novo%20motif=1; 621 . 29829249 29829928 123,255,0
chr21 10806896 10807387 ID=SRX360015;Name=MYNN%20(@%20LoVo);Title=GSM1239583:%20batch5%20chrom1%20LoVo%20MYNN%20Rabbit%20FailedQC%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Digestive%20tract;
source_name=LoVo;cell%20line=LoVo;cell%20type=colon%20adenocarcinoma;hgn=MYNN;antibody=Abcam%20:%20ab66273;control%20sample=batch5_chrom1_LoVo_IgG_Rabbit;qc%20successful=FailedQC;fraction%20of%20peaks%20close%20to%20tss=0.060241;lowest%20e-value%20for%20a%20high%20complexity%20de%20novo%20motif=1; 142 . 10806896 10807387 0,144,255
chr21 10819237 10819956 ID=SRX360015;Name=MYNN%20(@%20LoVo);Title=GSM1239583:%20batch5%20chrom1%20LoVo%20MYNN%20Rabbit%20FailedQC%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Digestive%20tract;
source_name=LoVo;cell%20line=LoVo;cell%20type=colon%20adenocarcinoma;hgn=MYNN;antibody=Abcam%20:%20ab66273;control%20sample=batch5_chrom1_LoVo_IgG_Rabbit;qc%20successful=FailedQC;fraction%20of%20peaks%20close%20to%20tss=0.060241;lowest%20e-value%20for%20a%20high%20complexity%20de%20novo%20motif=1; 690 . 10819237 10819956 193,255,0
chr21 11186245 11186877 ID=SRX360015;Name=MYNN%20(@%20LoVo);Title=GSM1239583:%20batch5%20chrom1%20LoVo%20MYNN%20Rabbit%20FailedQC%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Digestive%20tract;
source_name=LoVo;cell%20line=LoVo;cell%20type=colon%20adenocarcinoma;hgn=MYNN;antibody=Abcam%20:%20ab66273;control%20sample=batch5_chrom1_LoVo_IgG_Rabbit;qc%20successful=FailedQC;fraction%20of%20peaks%20close%20to%20tss=0.060241;lowest%20e-value%20for%20a%20high%20complexity%20de%20novo%20motif=1; 667 . 11186245 11186877 170,255,0
chr22 18688119 18688396 ID=SRX360015;Name=MYNN%20(@%20LoVo);Title=GSM1239583:%20batch5%20chrom1%20LoVo%20MYNN%20Rabbit%20FailedQC%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Digestive%20tract;
source_name=LoVo;cell%20line=LoVo;cell%20type=colon%20adenocarcinoma;hgn=MYNN;antibody=Abcam%20:%20ab66273;control%20sample=batch5_chrom1_LoVo_IgG_Rabbit;qc%20successful=FailedQC;fraction%20of%20peaks%20close%20to%20tss=0.060241;lowest%20e-value%20for%20a%20high%20complexity%20de%20novo%20motif=1; 153 . 18688119 18688396 0,156,255
chr22 18879984 18880261 ID=SRX360015;Name=MYNN%20(@%20LoVo);Title=GSM1239583:%20batch5%20chrom1%20LoVo%20MYNN%20Rabbit%20FailedQC%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Digestive%20tract;
source_name=LoVo;cell%20line=LoVo;cell%20type=colon%20adenocarcinoma;hgn=MYNN;antibody=Abcam%20:%20ab66273;control%20sample=batch5_chrom1_LoVo_IgG_Rabbit;qc%20successful=FailedQC;fraction%20of%20peaks%20close%20to%20tss=0.060241;lowest%20e-value%20for%20a%20high%20complexity%20de%20novo%20motif=1; 171 . 18879984 18880261 0,174,255
chr22 18883761 18884231 ID=SRX360015;Name=MYNN%20(@%20LoVo);Title=GSM1239583:%20batch5%20chrom1%20LoVo%20MYNN%20Rabbit%20FailedQC%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Digestive%20tract;
source_name=LoVo;cell%20line=LoVo;cell%20type=colon%20adenocarcinoma;hgn=MYNN;antibody=Abcam%20:%20ab66273;control%20sample=batch5_chrom1_LoVo_IgG_Rabbit;qc%20successful=FailedQC;fraction%20of%20peaks%20close%20to%20tss=0.060241;lowest%20e-value%20for%20a%20high%20complexity%20de%20novo%20motif=1; 229 . 18883761 18884231 0,233,255
chr22 20689305 20689714 ID=SRX360015;Name=MYNN%20(@%20LoVo);Title=GSM1239583:%20batch5%20chrom1%20LoVo%20MYNN%20Rabbit%20FailedQC%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Digestive%20tract;
source_name=LoVo;cell%20line=LoVo;cell%20type=colon%20adenocarcinoma;hgn=MYNN;antibody=Abcam%20:%20ab66273;control%20sample=batch5_chrom1_LoVo_IgG_Rabbit;qc%20successful=FailedQC;fraction%20of%20peaks%20close%20to%20tss=0.060241;lowest%20e-value%20for%20a%20high%20complexity%20de%20novo%20motif=1; 219 . 20689305 20689714 0,223,255
chr3 196625423 196625992 ID=SRX360015;Name=MYNN%20(@%20LoVo);Title=GSM1239583:%20batch5%20chrom1%20LoVo%20MYNN%20Rabbit%20FailedQC%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Digestive%20tract;
source_name=LoVo;cell%20line=LoVo;cell%20type=colon%20adenocarcinoma;hgn=MYNN;antibody=Abcam%20:%20ab66273;control%20sample=batch5_chrom1_LoVo_IgG_Rabbit;qc%20successful=FailedQC;fraction%20of%20peaks%20close%20to%20tss=0.060241;lowest%20e-value%20for%20a%20high%20complexity%20de%20novo%20motif=1; 1000 . 196625423 196625992 255,0,0
chr4 21583432 21583925 ID=SRX360015;Name=MYNN%20(@%20LoVo);Title=GSM1239583:%20batch5%20chrom1%20LoVo%20MYNN%20Rabbit%20FailedQC%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Digestive%20tract;
source_name=LoVo;cell%20line=LoVo;cell%20type=colon%20adenocarcinoma;hgn=MYNN;antibody=Abcam%20:%20ab66273;control%20sample=batch5_chrom1_LoVo_IgG_Rabbit;qc%20successful=FailedQC;fraction%20of%20peaks%20close%20to%20tss=0.060241;lowest%20e-value%20for%20a%20high%20complexity%20de%20novo%20motif=1; 205 . 21583432 21583925 0,209,255
chr4 49636139 49636417 ID=SRX360015;Name=MYNN%20(@%20LoVo);Title=GSM1239583:%20batch5%20chrom1%20LoVo%20MYNN%20Rabbit%20FailedQC%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Digestive%20tract;
source_name=LoVo;cell%20line=LoVo;cell%20type=colon%20adenocarcinoma;hgn=MYNN;antibody=Abcam%20:%20ab66273;control%20sample=batch5_chrom1_LoVo_IgG_Rabbit;qc%20successful=FailedQC;fraction%20of%20peaks%20close%20to%20tss=0.060241;lowest%20e-value%20for%20a%20high%20complexity%20de%20novo%20motif=1; 115 . 49636139 49636417 0,117,255
chr4 49659383 49659909 ID=SRX360015;Name=MYNN%20(@%20LoVo);Title=GSM1239583:%20batch5%20chrom1%20LoVo%20MYNN%20Rabbit%20FailedQC%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Digestive%20tract;
source_name=LoVo;cell%20line=LoVo;cell%20type=colon%20adenocarcinoma;hgn=MYNN;antibody=Abcam%20:%20ab66273;control%20sample=batch5_chrom1_LoVo_IgG_Rabbit;qc%20successful=FailedQC;fraction%20of%20peaks%20close%20to%20tss=0.060241;lowest%20e-value%20for%20a%20high%20complexity%20de%20novo%20motif=1; 196 . 49659383 49659909 0,199,255
chr4 68264997 68265921 ID=SRX360015;Name=MYNN%20(@%20LoVo);Title=GSM1239583:%20batch5%20chrom1%20LoVo%20MYNN%20Rabbit%20FailedQC%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Digestive%20tract;
source_name=LoVo;cell%20line=LoVo;cell%20type=colon%20adenocarcinoma;hgn=MYNN;antibody=Abcam%20:%20ab66273;control%20sample=batch5_chrom1_LoVo_IgG_Rabbit;qc%20successful=FailedQC;fraction%20of%20peaks%20close%20to%20tss=0.060241;lowest%20e-value%20for%20a%20high%20complexity%20de%20novo%20motif=1; 409 . 68264997 68265921 0,255,92
chr4 68266132 68266496 ID=SRX360015;Name=MYNN%20(@%20LoVo);Title=GSM1239583:%20batch5%20chrom1%20LoVo%20MYNN%20Rabbit%20FailedQC%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Digestive%20tract;
source_name=LoVo;cell%20line=LoVo;cell%20type=colon%20adenocarcinoma;hgn=MYNN;antibody=Abcam%20:%20ab66273;control%20sample=batch5_chrom1_LoVo_IgG_Rabbit;qc%20successful=FailedQC;fraction%20of%20peaks%20close%20to%20tss=0.060241;lowest%20e-value%20for%20a%20high%20complexity%20de%20novo%20motif=1; 126 . 68266132 68266496 0,128,255
chr4 190156147 190156586 ID=SRX360015;Name=MYNN%20(@%20LoVo);Title=GSM1239583:%20batch5%20chrom1%20LoVo%20MYNN%20Rabbit%20FailedQC%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Digestive%20tract;
source_name=LoVo;cell%20line=LoVo;cell%20type=colon%20adenocarcinoma;hgn=MYNN;antibody=Abcam%20:%20ab66273;control%20sample=batch5_chrom1_LoVo_IgG_Rabbit;qc%20successful=FailedQC;fraction%20of%20peaks%20close%20to%20tss=0.060241;lowest%20e-value%20for%20a%20high%20complexity%20de%20novo%20motif=1; 209 . 190156147 190156586 0,213,255
chr4 191043857 191044225 ID=SRX360015;Name=MYNN%20(@%20LoVo);Title=GSM1239583:%20batch5%20chrom1%20LoVo%20MYNN%20Rabbit%20FailedQC%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Digestive%20tract;
source_name=LoVo;cell%20line=LoVo;cell%20type=colon%20adenocarcinoma;hgn=MYNN;antibody=Abcam%20:%20ab66273;control%20sample=batch5_chrom1_LoVo_IgG_Rabbit;qc%20successful=FailedQC;fraction%20of%20peaks%20close%20to%20tss=0.060241;lowest%20e-value%20for%20a%20high%20complexity%20de%20novo%20motif=1; 195 . 191043857 191044225 0,198,255
chr5 10102 11768 ID=SRX360015;Name=MYNN%20(@%20LoVo);Title=GSM1239583:%20batch5%20chrom1%20LoVo%20MYNN%20Rabbit%20FailedQC%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Digestive%20tract;
source_name=LoVo;cell%20line=LoVo;cell%20type=colon%20adenocarcinoma;hgn=MYNN;antibody=Abcam%20:%20ab66273;control%20sample=batch5_chrom1_LoVo_IgG_Rabbit;qc%20successful=FailedQC;fraction%20of%20peaks%20close%20to%20tss=0.060241;lowest%20e-value%20for%20a%20high%20complexity%20de%20novo%20motif=1; 275 . 10102 11768 0,255,229
chr5 344431 344743 ID=SRX360015;Name=MYNN%20(@%20LoVo);Title=GSM1239583:%20batch5%20chrom1%20LoVo%20MYNN%20Rabbit%20FailedQC%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Digestive%20tract;
source_name=LoVo;cell%20line=LoVo;cell%20type=colon%20adenocarcinoma;hgn=MYNN;antibody=Abcam%20:%20ab66273;control%20sample=batch5_chrom1_LoVo_IgG_Rabbit;qc%20successful=FailedQC;fraction%20of%20peaks%20close%20to%20tss=0.060241;lowest%20e-value%20for%20a%20high%20complexity%20de%20novo%20motif=1; 198 . 344431 344743 0,201,255
chr5 178012566 178012901 ID=SRX360015;Name=MYNN%20(@%20LoVo);Title=GSM1239583:%20batch5%20chrom1%20LoVo%20MYNN%20Rabbit%20FailedQC%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Digestive%20tract;
source_name=LoVo;cell%20line=LoVo;cell%20type=colon%20adenocarcinoma;hgn=MYNN;antibody=Abcam%20:%20ab66273;control%20sample=batch5_chrom1_LoVo_IgG_Rabbit;qc%20successful=FailedQC;fraction%20of%20peaks%20close%20to%20tss=0.060241;lowest%20e-value%20for%20a%20high%20complexity%20de%20novo%20motif=1; 174 . 178012566 178012901 0,177,255
chr6 58776264 58779558 ID=SRX360015;Name=MYNN%20(@%20LoVo);Title=GSM1239583:%20batch5%20chrom1%20LoVo%20MYNN%20Rabbit%20FailedQC%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Digestive%20tract;
source_name=LoVo;cell%20line=LoVo;cell%20type=colon%20adenocarcinoma;hgn=MYNN;antibody=Abcam%20:%20ab66273;control%20sample=batch5_chrom1_LoVo_IgG_Rabbit;qc%20successful=FailedQC;fraction%20of%20peaks%20close%20to%20tss=0.060241;lowest%20e-value%20for%20a%20high%20complexity%20de%20novo%20motif=1; 567 . 58776264 58779558 68,255,0
chr6 61914028 61914408 ID=SRX360015;Name=MYNN%20(@%20LoVo);Title=GSM1239583:%20batch5%20chrom1%20LoVo%20MYNN%20Rabbit%20FailedQC%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Digestive%20tract;
source_name=LoVo;cell%20line=LoVo;cell%20type=colon%20adenocarcinoma;hgn=MYNN;antibody=Abcam%20:%20ab66273;control%20sample=batch5_chrom1_LoVo_IgG_Rabbit;qc%20successful=FailedQC;fraction%20of%20peaks%20close%20to%20tss=0.060241;lowest%20e-value%20for%20a%20high%20complexity%20de%20novo%20motif=1; 249 . 61914028 61914408 0,253,255
chr7 1311918 1312235 ID=SRX360015;Name=MYNN%20(@%20LoVo);Title=GSM1239583:%20batch5%20chrom1%20LoVo%20MYNN%20Rabbit%20FailedQC%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Digestive%20tract;
source_name=LoVo;cell%20line=LoVo;cell%20type=colon%20adenocarcinoma;hgn=MYNN;antibody=Abcam%20:%20ab66273;control%20sample=batch5_chrom1_LoVo_IgG_Rabbit;qc%20successful=FailedQC;fraction%20of%20peaks%20close%20to%20tss=0.060241;lowest%20e-value%20for%20a%20high%20complexity%20de%20novo%20motif=1; 140 . 1311918 1312235 0,142,255
chr7 61055511 61055960 ID=SRX360015;Name=MYNN%20(@%20LoVo);Title=GSM1239583:%20batch5%20chrom1%20LoVo%20MYNN%20Rabbit%20FailedQC%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Digestive%20tract;
source_name=LoVo;cell%20line=LoVo;cell%20type=colon%20adenocarcinoma;hgn=MYNN;antibody=Abcam%20:%20ab66273;control%20sample=batch5_chrom1_LoVo_IgG_Rabbit;qc%20successful=FailedQC;fraction%20of%20peaks%20close%20to%20tss=0.060241;lowest%20e-value%20for%20a%20high%20complexity%20de%20novo%20motif=1; 245 . 61055511 61055960 0,249,255
chr7 61800935 61801212 ID=SRX360015;Name=MYNN%20(@%20LoVo);Title=GSM1239583:%20batch5%20chrom1%20LoVo%20MYNN%20Rabbit%20FailedQC%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Digestive%20tract;
source_name=LoVo;cell%20line=LoVo;cell%20type=colon%20adenocarcinoma;hgn=MYNN;antibody=Abcam%20:%20ab66273;control%20sample=batch5_chrom1_LoVo_IgG_Rabbit;qc%20successful=FailedQC;fraction%20of%20peaks%20close%20to%20tss=0.060241;lowest%20e-value%20for%20a%20high%20complexity%20de%20novo%20motif=1; 126 . 61800935 61801212 0,128,255
chr7 61968451 61969734 ID=SRX360015;Name=MYNN%20(@%20LoVo);Title=GSM1239583:%20batch5%20chrom1%20LoVo%20MYNN%20Rabbit%20FailedQC%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Digestive%20tract;
source_name=LoVo;cell%20line=LoVo;cell%20type=colon%20adenocarcinoma;hgn=MYNN;antibody=Abcam%20:%20ab66273;control%20sample=batch5_chrom1_LoVo_IgG_Rabbit;qc%20successful=FailedQC;fraction%20of%20peaks%20close%20to%20tss=0.060241;lowest%20e-value%20for%20a%20high%20complexity%20de%20novo%20motif=1; 923 . 61968451 61969734 255,78,0
chr7 61970078 61970581 ID=SRX360015;Name=MYNN%20(@%20LoVo);Title=GSM1239583:%20batch5%20chrom1%20LoVo%20MYNN%20Rabbit%20FailedQC%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Digestive%20tract;
source_name=LoVo;cell%20line=LoVo;cell%20type=colon%20adenocarcinoma;hgn=MYNN;antibody=Abcam%20:%20ab66273;control%20sample=batch5_chrom1_LoVo_IgG_Rabbit;qc%20successful=FailedQC;fraction%20of%20peaks%20close%20to%20tss=0.060241;lowest%20e-value%20for%20a%20high%20complexity%20de%20novo%20motif=1; 334 . 61970078 61970581 0,255,169
chr7 64954096 64955031 ID=SRX360015;Name=MYNN%20(@%20LoVo);Title=GSM1239583:%20batch5%20chrom1%20LoVo%20MYNN%20Rabbit%20FailedQC%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Digestive%20tract;
source_name=LoVo;cell%20line=LoVo;cell%20type=colon%20adenocarcinoma;hgn=MYNN;antibody=Abcam%20:%20ab66273;control%20sample=batch5_chrom1_LoVo_IgG_Rabbit;qc%20successful=FailedQC;fraction%20of%20peaks%20close%20to%20tss=0.060241;lowest%20e-value%20for%20a%20high%20complexity%20de%20novo%20motif=1; 257 . 64954096 64955031 0,255,247
chr7 158387695 158388210 ID=SRX360015;Name=MYNN%20(@%20LoVo);Title=GSM1239583:%20batch5%20chrom1%20LoVo%20MYNN%20Rabbit%20FailedQC%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Digestive%20tract;
source_name=LoVo;cell%20line=LoVo;cell%20type=colon%20adenocarcinoma;hgn=MYNN;antibody=Abcam%20:%20ab66273;control%20sample=batch5_chrom1_LoVo_IgG_Rabbit;qc%20successful=FailedQC;fraction%20of%20peaks%20close%20to%20tss=0.060241;lowest%20e-value%20for%20a%20high%20complexity%20de%20novo%20motif=1; 430 . 158387695 158388210 0,255,71
chr8 43092858 43093282 ID=SRX360015;Name=MYNN%20(@%20LoVo);Title=GSM1239583:%20batch5%20chrom1%20LoVo%20MYNN%20Rabbit%20FailedQC%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Digestive%20tract;
source_name=LoVo;cell%20line=LoVo;cell%20type=colon%20adenocarcinoma;hgn=MYNN;antibody=Abcam%20:%20ab66273;control%20sample=batch5_chrom1_LoVo_IgG_Rabbit;qc%20successful=FailedQC;fraction%20of%20peaks%20close%20to%20tss=0.060241;lowest%20e-value%20for%20a%20high%20complexity%20de%20novo%20motif=1; 255 . 43092858 43093282 0,255,249
chr8 43094774 43095313 ID=SRX360015;Name=MYNN%20(@%20LoVo);Title=GSM1239583:%20batch5%20chrom1%20LoVo%20MYNN%20Rabbit%20FailedQC%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Digestive%20tract;
source_name=LoVo;cell%20line=LoVo;cell%20type=colon%20adenocarcinoma;hgn=MYNN;antibody=Abcam%20:%20ab66273;control%20sample=batch5_chrom1_LoVo_IgG_Rabbit;qc%20successful=FailedQC;fraction%20of%20peaks%20close%20to%20tss=0.060241;lowest%20e-value%20for%20a%20high%20complexity%20de%20novo%20motif=1; 215 . 43094774 43095313 0,219,255
chr8 43772043 43772416 ID=SRX360015;Name=MYNN%20(@%20LoVo);Title=GSM1239583:%20batch5%20chrom1%20LoVo%20MYNN%20Rabbit%20FailedQC%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Digestive%20tract;
source_name=LoVo;cell%20line=LoVo;cell%20type=colon%20adenocarcinoma;hgn=MYNN;antibody=Abcam%20:%20ab66273;control%20sample=batch5_chrom1_LoVo_IgG_Rabbit;qc%20successful=FailedQC;fraction%20of%20peaks%20close%20to%20tss=0.060241;lowest%20e-value%20for%20a%20high%20complexity%20de%20novo%20motif=1; 229 . 43772043 43772416 0,233,255
chr8 43793543 43794121 ID=SRX360015;Name=MYNN%20(@%20LoVo);Title=GSM1239583:%20batch5%20chrom1%20LoVo%20MYNN%20Rabbit%20FailedQC%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Digestive%20tract;
source_name=LoVo;cell%20line=LoVo;cell%20type=colon%20adenocarcinoma;hgn=MYNN;antibody=Abcam%20:%20ab66273;control%20sample=batch5_chrom1_LoVo_IgG_Rabbit;qc%20successful=FailedQC;fraction%20of%20peaks%20close%20to%20tss=0.060241;lowest%20e-value%20for%20a%20high%20complexity%20de%20novo%20motif=1; 209 . 43793543 43794121 0,213,255
chr8 43794595 43794877 ID=SRX360015;Name=MYNN%20(@%20LoVo);Title=GSM1239583:%20batch5%20chrom1%20LoVo%20MYNN%20Rabbit%20FailedQC%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Digestive%20tract;
source_name=LoVo;cell%20line=LoVo;cell%20type=colon%20adenocarcinoma;hgn=MYNN;antibody=Abcam%20:%20ab66273;control%20sample=batch5_chrom1_LoVo_IgG_Rabbit;qc%20successful=FailedQC;fraction%20of%20peaks%20close%20to%20tss=0.060241;lowest%20e-value%20for%20a%20high%20complexity%20de%20novo%20motif=1; 133 . 43794595 43794877 0,135,255
chr9 42415800 42416082 ID=SRX360015;Name=MYNN%20(@%20LoVo);Title=GSM1239583:%20batch5%20chrom1%20LoVo%20MYNN%20Rabbit%20FailedQC%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Digestive%20tract;
source_name=LoVo;cell%20line=LoVo;cell%20type=colon%20adenocarcinoma;hgn=MYNN;antibody=Abcam%20:%20ab66273;control%20sample=batch5_chrom1_LoVo_IgG_Rabbit;qc%20successful=FailedQC;fraction%20of%20peaks%20close%20to%20tss=0.060241;lowest%20e-value%20for%20a%20high%20complexity%20de%20novo%20motif=1; 205 . 42415800 42416082 0,209,255
chr9 44070500 44071000 ID=SRX360015;Name=MYNN%20(@%20LoVo);Title=GSM1239583:%20batch5%20chrom1%20LoVo%20MYNN%20Rabbit%20FailedQC%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Digestive%20tract;
source_name=LoVo;cell%20line=LoVo;cell%20type=colon%20adenocarcinoma;hgn=MYNN;antibody=Abcam%20:%20ab66273;control%20sample=batch5_chrom1_LoVo_IgG_Rabbit;qc%20successful=FailedQC;fraction%20of%20peaks%20close%20to%20tss=0.060241;lowest%20e-value%20for%20a%20high%20complexity%20de%20novo%20motif=1; 326 . 44070500 44071000 0,255,177
chr9 66970896 66971605 ID=SRX360015;Name=MYNN%20(@%20LoVo);Title=GSM1239583:%20batch5%20chrom1%20LoVo%20MYNN%20Rabbit%20FailedQC%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Digestive%20tract;
source_name=LoVo;cell%20line=LoVo;cell%20type=colon%20adenocarcinoma;hgn=MYNN;antibody=Abcam%20:%20ab66273;control%20sample=batch5_chrom1_LoVo_IgG_Rabbit;qc%20successful=FailedQC;fraction%20of%20peaks%20close%20to%20tss=0.060241;lowest%20e-value%20for%20a%20high%20complexity%20de%20novo%20motif=1; 401 . 66970896 66971605 0,255,100
chr9 67320527 67321048 ID=SRX360015;Name=MYNN%20(@%20LoVo);Title=GSM1239583:%20batch5%20chrom1%20LoVo%20MYNN%20Rabbit%20FailedQC%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Digestive%20tract;
source_name=LoVo;cell%20line=LoVo;cell%20type=colon%20adenocarcinoma;hgn=MYNN;antibody=Abcam%20:%20ab66273;control%20sample=batch5_chrom1_LoVo_IgG_Rabbit;qc%20successful=FailedQC;fraction%20of%20peaks%20close%20to%20tss=0.060241;lowest%20e-value%20for%20a%20high%20complexity%20de%20novo%20motif=1; 385 . 67320527 67321048 0,255,117
chr9 69710721 69711422 ID=SRX360015;Name=MYNN%20(@%20LoVo);Title=GSM1239583:%20batch5%20chrom1%20LoVo%20MYNN%20Rabbit%20FailedQC%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Digestive%20tract;
source_name=LoVo;cell%20line=LoVo;cell%20type=colon%20adenocarcinoma;hgn=MYNN;antibody=Abcam%20:%20ab66273;control%20sample=batch5_chrom1_LoVo_IgG_Rabbit;qc%20successful=FailedQC;fraction%20of%20peaks%20close%20to%20tss=0.060241;lowest%20e-value%20for%20a%20high%20complexity%20de%20novo%20motif=1; 362 . 69710721 69711422 0,255,140
chr9 72652910 72653625 ID=SRX360015;Name=MYNN%20(@%20LoVo);Title=GSM1239583:%20batch5%20chrom1%20LoVo%20MYNN%20Rabbit%20FailedQC%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Digestive%20tract;
source_name=LoVo;cell%20line=LoVo;cell%20type=colon%20adenocarcinoma;hgn=MYNN;antibody=Abcam%20:%20ab66273;control%20sample=batch5_chrom1_LoVo_IgG_Rabbit;qc%20successful=FailedQC;fraction%20of%20peaks%20close%20to%20tss=0.060241;lowest%20e-value%20for%20a%20high%20complexity%20de%20novo%20motif=1; 701 . 72652910 72653625 205,255,0
chr9 78789903 78790193 ID=SRX360015;Name=MYNN%20(@%20LoVo);Title=GSM1239583:%20batch5%20chrom1%20LoVo%20MYNN%20Rabbit%20FailedQC%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Digestive%20tract;
source_name=LoVo;cell%20line=LoVo;cell%20type=colon%20adenocarcinoma;hgn=MYNN;antibody=Abcam%20:%20ab66273;control%20sample=batch5_chrom1_LoVo_IgG_Rabbit;qc%20successful=FailedQC;fraction%20of%20peaks%20close%20to%20tss=0.060241;lowest%20e-value%20for%20a%20high%20complexity%20de%20novo%20motif=1; 177 . 78789903 78790193 0,180,255
chr9_gl000199_random 34202 34712 ID=SRX360015;Name=MYNN%20(@%20LoVo);Title=GSM1239583:%20batch5%20chrom1%20LoVo%20MYNN%20Rabbit%20FailedQC%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Digestive%20tract;
source_name=LoVo;cell%20line=LoVo;cell%20type=colon%20adenocarcinoma;hgn=MYNN;antibody=Abcam%20:%20ab66273;control%20sample=batch5_chrom1_LoVo_IgG_Rabbit;qc%20successful=FailedQC;fraction%20of%20peaks%20close%20to%20tss=0.060241;lowest%20e-value%20for%20a%20high%20complexity%20de%20novo%20motif=1; 282 . 34202 34712 0,255,222
chr9_gl000199_random 168055 168571 ID=SRX360015;Name=MYNN%20(@%20LoVo);Title=GSM1239583:%20batch5%20chrom1%20LoVo%20MYNN%20Rabbit%20FailedQC%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Digestive%20tract;
source_name=LoVo;cell%20line=LoVo;cell%20type=colon%20adenocarcinoma;hgn=MYNN;antibody=Abcam%20:%20ab66273;control%20sample=batch5_chrom1_LoVo_IgG_Rabbit;qc%20successful=FailedQC;fraction%20of%20peaks%20close%20to%20tss=0.060241;lowest%20e-value%20for%20a%20high%20complexity%20de%20novo%20motif=1; 250 . 168055 168571 0,255,255
chrUn_gl000212 40623 41158 ID=SRX360015;Name=MYNN%20(@%20LoVo);Title=GSM1239583:%20batch5%20chrom1%20LoVo%20MYNN%20Rabbit%20FailedQC%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Digestive%20tract;
source_name=LoVo;cell%20line=LoVo;cell%20type=colon%20adenocarcinoma;hgn=MYNN;antibody=Abcam%20:%20ab66273;control%20sample=batch5_chrom1_LoVo_IgG_Rabbit;qc%20successful=FailedQC;fraction%20of%20peaks%20close%20to%20tss=0.060241;lowest%20e-value%20for%20a%20high%20complexity%20de%20novo%20motif=1; 281 . 40623 41158 0,255,223
chrUn_gl000214 64151 65721 ID=SRX360015;Name=MYNN%20(@%20LoVo);Title=GSM1239583:%20batch5%20chrom1%20LoVo%20MYNN%20Rabbit%20FailedQC%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Digestive%20tract;
source_name=LoVo;cell%20line=LoVo;cell%20type=colon%20adenocarcinoma;hgn=MYNN;antibody=Abcam%20:%20ab66273;control%20sample=batch5_chrom1_LoVo_IgG_Rabbit;qc%20successful=FailedQC;fraction%20of%20peaks%20close%20to%20tss=0.060241;lowest%20e-value%20for%20a%20high%20complexity%20de%20novo%20motif=1; 715 . 64151 65721 219,255,0
chrUn_gl000216 1327 1871 ID=SRX360015;Name=MYNN%20(@%20LoVo);Title=GSM1239583:%20batch5%20chrom1%20LoVo%20MYNN%20Rabbit%20FailedQC%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Digestive%20tract;
source_name=LoVo;cell%20line=LoVo;cell%20type=colon%20adenocarcinoma;hgn=MYNN;antibody=Abcam%20:%20ab66273;control%20sample=batch5_chrom1_LoVo_IgG_Rabbit;qc%20successful=FailedQC;fraction%20of%20peaks%20close%20to%20tss=0.060241;lowest%20e-value%20for%20a%20high%20complexity%20de%20novo%20motif=1; 301 . 1327 1871 0,255,202
chrUn_gl000216 75554 76278 ID=SRX360015;Name=MYNN%20(@%20LoVo);Title=GSM1239583:%20batch5%20chrom1%20LoVo%20MYNN%20Rabbit%20FailedQC%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Digestive%20tract;
source_name=LoVo;cell%20line=LoVo;cell%20type=colon%20adenocarcinoma;hgn=MYNN;antibody=Abcam%20:%20ab66273;control%20sample=batch5_chrom1_LoVo_IgG_Rabbit;qc%20successful=FailedQC;fraction%20of%20peaks%20close%20to%20tss=0.060241;lowest%20e-value%20for%20a%20high%20complexity%20de%20novo%20motif=1; 886 . 75554 76278 255,116,0
chrUn_gl000220 102368 103961 ID=SRX360015;Name=MYNN%20(@%20LoVo);Title=GSM1239583:%20batch5%20chrom1%20LoVo%20MYNN%20Rabbit%20FailedQC%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Digestive%20tract;
source_name=LoVo;cell%20line=LoVo;cell%20type=colon%20adenocarcinoma;hgn=MYNN;antibody=Abcam%20:%20ab66273;control%20sample=batch5_chrom1_LoVo_IgG_Rabbit;qc%20successful=FailedQC;fraction%20of%20peaks%20close%20to%20tss=0.060241;lowest%20e-value%20for%20a%20high%20complexity%20de%20novo%20motif=1; 296 . 102368 103961 0,255,208
chrUn_gl000220 109980 110811 ID=SRX360015;Name=MYNN%20(@%20LoVo);Title=GSM1239583:%20batch5%20chrom1%20LoVo%20MYNN%20Rabbit%20FailedQC%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Digestive%20tract;
source_name=LoVo;cell%20line=LoVo;cell%20type=colon%20adenocarcinoma;hgn=MYNN;antibody=Abcam%20:%20ab66273;control%20sample=batch5_chrom1_LoVo_IgG_Rabbit;qc%20successful=FailedQC;fraction%20of%20peaks%20close%20to%20tss=0.060241;lowest%20e-value%20for%20a%20high%20complexity%20de%20novo%20motif=1; 203 . 109980 110811 0,207,255
chrUn_gl000220 121089 121375 ID=SRX360015;Name=MYNN%20(@%20LoVo);Title=GSM1239583:%20batch5%20chrom1%20LoVo%20MYNN%20Rabbit%20FailedQC%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Digestive%20tract;
source_name=LoVo;cell%20line=LoVo;cell%20type=colon%20adenocarcinoma;hgn=MYNN;antibody=Abcam%20:%20ab66273;control%20sample=batch5_chrom1_LoVo_IgG_Rabbit;qc%20successful=FailedQC;fraction%20of%20peaks%20close%20to%20tss=0.060241;lowest%20e-value%20for%20a%20high%20complexity%20de%20novo%20motif=1; 148 . 121089 121375 0,150,255
chrUn_gl000220 153945 154771 ID=SRX360015;Name=MYNN%20(@%20LoVo);Title=GSM1239583:%20batch5%20chrom1%20LoVo%20MYNN%20Rabbit%20FailedQC%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Digestive%20tract;
source_name=LoVo;cell%20line=LoVo;cell%20type=colon%20adenocarcinoma;hgn=MYNN;antibody=Abcam%20:%20ab66273;control%20sample=batch5_chrom1_LoVo_IgG_Rabbit;qc%20successful=FailedQC;fraction%20of%20peaks%20close%20to%20tss=0.060241;lowest%20e-value%20for%20a%20high%20complexity%20de%20novo%20motif=1; 193 . 153945 154771 0,196,255
chrUn_gl000220 158922 159256 ID=SRX360015;Name=MYNN%20(@%20LoVo);Title=GSM1239583:%20batch5%20chrom1%20LoVo%20MYNN%20Rabbit%20FailedQC%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Digestive%20tract;
source_name=LoVo;cell%20line=LoVo;cell%20type=colon%20adenocarcinoma;hgn=MYNN;antibody=Abcam%20:%20ab66273;control%20sample=batch5_chrom1_LoVo_IgG_Rabbit;qc%20successful=FailedQC;fraction%20of%20peaks%20close%20to%20tss=0.060241;lowest%20e-value%20for%20a%20high%20complexity%20de%20novo%20motif=1; 230 . 158922 159256 0,234,255
chrUn_gl000225 67267 67571 ID=SRX360015;Name=MYNN%20(@%20LoVo);Title=GSM1239583:%20batch5%20chrom1%20LoVo%20MYNN%20Rabbit%20FailedQC%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Digestive%20tract;
source_name=LoVo;cell%20line=LoVo;cell%20type=colon%20adenocarcinoma;hgn=MYNN;antibody=Abcam%20:%20ab66273;control%20sample=batch5_chrom1_LoVo_IgG_Rabbit;qc%20successful=FailedQC;fraction%20of%20peaks%20close%20to%20tss=0.060241;lowest%20e-value%20for%20a%20high%20complexity%20de%20novo%20motif=1; 170 . 67267 67571 0,173,255
chrUn_gl000225 196761 197254 ID=SRX360015;Name=MYNN%20(@%20LoVo);Title=GSM1239583:%20batch5%20chrom1%20LoVo%20MYNN%20Rabbit%20FailedQC%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Digestive%20tract;
source_name=LoVo;cell%20line=LoVo;cell%20type=colon%20adenocarcinoma;hgn=MYNN;antibody=Abcam%20:%20ab66273;control%20sample=batch5_chrom1_LoVo_IgG_Rabbit;qc%20successful=FailedQC;fraction%20of%20peaks%20close%20to%20tss=0.060241;lowest%20e-value%20for%20a%20high%20complexity%20de%20novo%20motif=1; 336 . 196761 197254 0,255,167
chrUn_gl000226 975 1305 ID=SRX360015;Name=MYNN%20(@%20LoVo);Title=GSM1239583:%20batch5%20chrom1%20LoVo%20MYNN%20Rabbit%20FailedQC%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Digestive%20tract;
source_name=LoVo;cell%20line=LoVo;cell%20type=colon%20adenocarcinoma;hgn=MYNN;antibody=Abcam%20:%20ab66273;control%20sample=batch5_chrom1_LoVo_IgG_Rabbit;qc%20successful=FailedQC;fraction%20of%20peaks%20close%20to%20tss=0.060241;lowest%20e-value%20for%20a%20high%20complexity%20de%20novo%20motif=1; 166 . 975 1305 0,169,255
chrUn_gl000226 13228 13570 ID=SRX360015;Name=MYNN%20(@%20LoVo);Title=GSM1239583:%20batch5%20chrom1%20LoVo%20MYNN%20Rabbit%20FailedQC%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Digestive%20tract;
source_name=LoVo;cell%20line=LoVo;cell%20type=colon%20adenocarcinoma;hgn=MYNN;antibody=Abcam%20:%20ab66273;control%20sample=batch5_chrom1_LoVo_IgG_Rabbit;qc%20successful=FailedQC;fraction%20of%20peaks%20close%20to%20tss=0.060241;lowest%20e-value%20for%20a%20high%20complexity%20de%20novo%20motif=1; 171 . 13228 13570 0,174,255
chrUn_gl000226 13835 14176 ID=SRX360015;Name=MYNN%20(@%20LoVo);Title=GSM1239583:%20batch5%20chrom1%20LoVo%20MYNN%20Rabbit%20FailedQC%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Digestive%20tract;
source_name=LoVo;cell%20line=LoVo;cell%20type=colon%20adenocarcinoma;hgn=MYNN;antibody=Abcam%20:%20ab66273;control%20sample=batch5_chrom1_LoVo_IgG_Rabbit;qc%20successful=FailedQC;fraction%20of%20peaks%20close%20to%20tss=0.060241;lowest%20e-value%20for%20a%20high%20complexity%20de%20novo%20motif=1; 103 . 13835 14176 0,105,255
chrUn_gl000226 14453 14899 ID=SRX360015;Name=MYNN%20(@%20LoVo);Title=GSM1239583:%20batch5%20chrom1%20LoVo%20MYNN%20Rabbit%20FailedQC%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Digestive%20tract;
source_name=LoVo;cell%20line=LoVo;cell%20type=colon%20adenocarcinoma;hgn=MYNN;antibody=Abcam%20:%20ab66273;control%20sample=batch5_chrom1_LoVo_IgG_Rabbit;qc%20successful=FailedQC;fraction%20of%20peaks%20close%20to%20tss=0.060241;lowest%20e-value%20for%20a%20high%20complexity%20de%20novo%20motif=1; 220 . 14453 14899 0,224,255
chrUn_gl000228 118273 118777 ID=SRX360015;Name=MYNN%20(@%20LoVo);Title=GSM1239583:%20batch5%20chrom1%20LoVo%20MYNN%20Rabbit%20FailedQC%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Digestive%20tract;
source_name=LoVo;cell%20line=LoVo;cell%20type=colon%20adenocarcinoma;hgn=MYNN;antibody=Abcam%20:%20ab66273;control%20sample=batch5_chrom1_LoVo_IgG_Rabbit;qc%20successful=FailedQC;fraction%20of%20peaks%20close%20to%20tss=0.060241;lowest%20e-value%20for%20a%20high%20complexity%20de%20novo%20motif=1; 133 . 118273 118777 0,135,255
chrX 58561164 58561660 ID=SRX360015;Name=MYNN%20(@%20LoVo);Title=GSM1239583:%20batch5%20chrom1%20LoVo%20MYNN%20Rabbit%20FailedQC%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Digestive%20tract;
source_name=LoVo;cell%20line=LoVo;cell%20type=colon%20adenocarcinoma;hgn=MYNN;antibody=Abcam%20:%20ab66273;control%20sample=batch5_chrom1_LoVo_IgG_Rabbit;qc%20successful=FailedQC;fraction%20of%20peaks%20close%20to%20tss=0.060241;lowest%20e-value%20for%20a%20high%20complexity%20de%20novo%20motif=1; 299 . 58561164 58561660 0,255,205
chrX 61881466 61881745 ID=SRX360015;Name=MYNN%20(@%20LoVo);Title=GSM1239583:%20batch5%20chrom1%20LoVo%20MYNN%20Rabbit%20FailedQC%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Digestive%20tract;
source_name=LoVo;cell%20line=LoVo;cell%20type=colon%20adenocarcinoma;hgn=MYNN;antibody=Abcam%20:%20ab66273;control%20sample=batch5_chrom1_LoVo_IgG_Rabbit;qc%20successful=FailedQC;fraction%20of%20peaks%20close%20to%20tss=0.060241;lowest%20e-value%20for%20a%20high%20complexity%20de%20novo%20motif=1; 199 . 61881466 61881745 0,202,255
chrX 155259852 155260481 ID=SRX360015;Name=MYNN%20(@%20LoVo);Title=GSM1239583:%20batch5%20chrom1%20LoVo%20MYNN%20Rabbit%20FailedQC%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Digestive%20tract;
source_name=LoVo;cell%20line=LoVo;cell%20type=colon%20adenocarcinoma;hgn=MYNN;antibody=Abcam%20:%20ab66273;control%20sample=batch5_chrom1_LoVo_IgG_Rabbit;qc%20successful=FailedQC;fraction%20of%20peaks%20close%20to%20tss=0.060241;lowest%20e-value%20for%20a%20high%20complexity%20de%20novo%20motif=1; 414 . 155259852 155260481 0,255,87
chrY 13140976 13141300 ID=SRX360015;Name=MYNN%20(@%20LoVo);Title=GSM1239583:%20batch5%20chrom1%20LoVo%20MYNN%20Rabbit%20FailedQC%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Digestive%20tract;
source_name=LoVo;cell%20line=LoVo;cell%20type=colon%20adenocarcinoma;hgn=MYNN;antibody=Abcam%20:%20ab66273;control%20sample=batch5_chrom1_LoVo_IgG_Rabbit;qc%20successful=FailedQC;fraction%20of%20peaks%20close%20to%20tss=0.060241;lowest%20e-value%20for%20a%20high%20complexity%20de%20novo%20motif=1; 131 . 13140976 13141300 0,133,255
chrY 13194862 13195254 ID=SRX360015;Name=MYNN%20(@%20LoVo);Title=GSM1239583:%20batch5%20chrom1%20LoVo%20MYNN%20Rabbit%20FailedQC%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Digestive%20tract;
source_name=LoVo;cell%20line=LoVo;cell%20type=colon%20adenocarcinoma;hgn=MYNN;antibody=Abcam%20:%20ab66273;control%20sample=batch5_chrom1_LoVo_IgG_Rabbit;qc%20successful=FailedQC;fraction%20of%20peaks%20close%20to%20tss=0.060241;lowest%20e-value%20for%20a%20high%20complexity%20de%20novo%20motif=1; 176 . 13194862 13195254 0,179,255
chrY 13650480 13650955 ID=SRX360015;Name=MYNN%20(@%20LoVo);Title=GSM1239583:%20batch5%20chrom1%20LoVo%20MYNN%20Rabbit%20FailedQC%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Digestive%20tract;
source_name=LoVo;cell%20line=LoVo;cell%20type=colon%20adenocarcinoma;hgn=MYNN;antibody=Abcam%20:%20ab66273;control%20sample=batch5_chrom1_LoVo_IgG_Rabbit;qc%20successful=FailedQC;fraction%20of%20peaks%20close%20to%20tss=0.060241;lowest%20e-value%20for%20a%20high%20complexity%20de%20novo%20motif=1; 271 . 13650480 13650955 0,255,233
chrY 13810832 13811374 ID=SRX360015;Name=MYNN%20(@%20LoVo);Title=GSM1239583:%20batch5%20chrom1%20LoVo%20MYNN%20Rabbit%20FailedQC%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Digestive%20tract;
source_name=LoVo;cell%20line=LoVo;cell%20type=colon%20adenocarcinoma;hgn=MYNN;antibody=Abcam%20:%20ab66273;control%20sample=batch5_chrom1_LoVo_IgG_Rabbit;qc%20successful=FailedQC;fraction%20of%20peaks%20close%20to%20tss=0.060241;lowest%20e-value%20for%20a%20high%20complexity%20de%20novo%20motif=1; 206 . 13810832 13811374 0,210,255
chrY 13842509 13842986 ID=SRX360015;Name=MYNN%20(@%20LoVo);Title=GSM1239583:%20batch5%20chrom1%20LoVo%20MYNN%20Rabbit%20FailedQC%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Digestive%20tract;
source_name=LoVo;cell%20line=LoVo;cell%20type=colon%20adenocarcinoma;hgn=MYNN;antibody=Abcam%20:%20ab66273;control%20sample=batch5_chrom1_LoVo_IgG_Rabbit;qc%20successful=FailedQC;fraction%20of%20peaks%20close%20to%20tss=0.060241;lowest%20e-value%20for%20a%20high%20complexity%20de%20novo%20motif=1; 347 . 13842509 13842986 0,255,156
chrY 13843692 13843988 ID=SRX360015;Name=MYNN%20(@%20LoVo);Title=GSM1239583:%20batch5%20chrom1%20LoVo%20MYNN%20Rabbit%20FailedQC%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Digestive%20tract;
source_name=LoVo;cell%20line=LoVo;cell%20type=colon%20adenocarcinoma;hgn=MYNN;antibody=Abcam%20:%20ab66273;control%20sample=batch5_chrom1_LoVo_IgG_Rabbit;qc%20successful=FailedQC;fraction%20of%20peaks%20close%20to%20tss=0.060241;lowest%20e-value%20for%20a%20high%20complexity%20de%20novo%20motif=1; 135 . 13843692 13843988 0,137,255
chrY 13868153 13868660 ID=SRX360015;Name=MYNN%20(@%20LoVo);Title=GSM1239583:%20batch5%20chrom1%20LoVo%20MYNN%20Rabbit%20FailedQC%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Digestive%20tract;
source_name=LoVo;cell%20line=LoVo;cell%20type=colon%20adenocarcinoma;hgn=MYNN;antibody=Abcam%20:%20ab66273;control%20sample=batch5_chrom1_LoVo_IgG_Rabbit;qc%20successful=FailedQC;fraction%20of%20peaks%20close%20to%20tss=0.060241;lowest%20e-value%20for%20a%20high%20complexity%20de%20novo%20motif=1; 233 . 13868153 13868660 0,237,255
chrY 58819570 58819870 ID=SRX360015;Name=MYNN%20(@%20LoVo);Title=GSM1239583:%20batch5%20chrom1%20LoVo%20MYNN%20Rabbit%20FailedQC%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Digestive%20tract;
source_name=LoVo;cell%20line=LoVo;cell%20type=colon%20adenocarcinoma;hgn=MYNN;antibody=Abcam%20:%20ab66273;control%20sample=batch5_chrom1_LoVo_IgG_Rabbit;qc%20successful=FailedQC;fraction%20of%20peaks%20close%20to%20tss=0.060241;lowest%20e-value%20for%20a%20high%20complexity%20de%20novo%20motif=1; 123 . 58819570 58819870 0,125,255
chrY 59362829 59363436 ID=SRX360015;Name=MYNN%20(@%20LoVo);Title=GSM1239583:%20batch5%20chrom1%20LoVo%20MYNN%20Rabbit%20FailedQC%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Digestive%20tract;
source_name=LoVo;cell%20line=LoVo;cell%20type=colon%20adenocarcinoma;hgn=MYNN;antibody=Abcam%20:%20ab66273;control%20sample=batch5_chrom1_LoVo_IgG_Rabbit;qc%20successful=FailedQC;fraction%20of%20peaks%20close%20to%20tss=0.060241;lowest%20e-value%20for%20a%20high%20complexity%20de%20novo%20motif=1; 340 . 59362829 59363436 0,255,163